Lilly to Seek FDA Approval for New Alzheimer's Drug

FRIDAY, June 25, 2021 (Healthday News) — Fresh on the heels of the U.S. Food and Drug Administration’s approval of the controversial Alzheimer’s drug Aduhelm, the maker of a second medicine that works in similar fashion said Thursday it hopes to…
Source: Topamax